These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33871158)
21. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery. Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772 [TBL] [Abstract][Full Text] [Related]
22. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
24. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. Gan Q; Wang T Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948 [TBL] [Abstract][Full Text] [Related]
25. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
26. Monodisperse Rattle-Structured Gold Nanorod-Mesoporous Silica Nanoparticles Core-Shell as Sulforaphane Carrier and its Sustained-Release Property. Manjili HK; Ma'mani L; Naderi-Manesh H Drug Res (Stuttg); 2018 Sep; 68(9):504-513. PubMed ID: 29660748 [TBL] [Abstract][Full Text] [Related]
27. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
28. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery. Tian Z; Xu Y; Zhu Y Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731 [TBL] [Abstract][Full Text] [Related]
29. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine. Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628 [TBL] [Abstract][Full Text] [Related]
30. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. Hu X; Wang Y; Peng B Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568 [TBL] [Abstract][Full Text] [Related]
31. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers. Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727 [TBL] [Abstract][Full Text] [Related]
32. Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles. Du G; Woythe L; van der Maaden K; Leone M; Romeijn S; Kros A; Kersten G; Jiskoot W; Bouwstra JA Pharm Res; 2018 Aug; 35(10):189. PubMed ID: 30105542 [TBL] [Abstract][Full Text] [Related]
34. Loading Effect of Chitosan Derivative Nanoparticles on Different Antigens and Their Immunomodulatory Activity on Dendritic Cells. Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677435 [TBL] [Abstract][Full Text] [Related]
35. Surface Modification of Mobile Composition of Matter (MCM)-41 Type Silica Nanoparticles for Potential Oral Mucosa Vaccine Delivery. Amin MK; Boateng JS J Pharm Sci; 2020 Jul; 109(7):2271-2283. PubMed ID: 32240692 [TBL] [Abstract][Full Text] [Related]
36. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
37. Interaction of bovine serum albumin with self-assembled nanoparticles of 6-O-cholesterol modified chitosan. Li X; Chen M; Yang W; Zhou Z; Liu L; Zhang Q Colloids Surf B Biointerfaces; 2012 Apr; 92():136-41. PubMed ID: 22178440 [TBL] [Abstract][Full Text] [Related]
38. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies. Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926 [TBL] [Abstract][Full Text] [Related]
39. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. Liu Z; Lv D; Liu S; Gong J; Wang D; Xiong M; Chen X; Xiang R; Tan X PLoS One; 2013; 8(4):e60190. PubMed ID: 23577091 [TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]